PrecisePEG

PrecisePEG is a biotechnology company focused on developing next-generation PEGylation technologies to improve the therapeutic profile of drugs. The company's proprietary platform enables the production of monodisperse, high-purity polyethylene glycol (PEG) derivatives with precise chain lengths, addressing the limitations of traditional polydisperse PEG mixtures. By providing well-defined chemical structures, PrecisePEG aims to enhance the stability, solubility, and pharmacokinetics of peptides, proteins, and small molecules. Their technology is designed to reduce immunogenicity and improve the safety and efficacy of conjugated therapeutics across various disease areas.